Wind统计显示，8月13日，申万31个一级行业中有26个行业获融资净买入，其中，非银金融行业获融资 净买入额居首，当日净买入23.13亿元；获融资净买入居前的行业还有通信、医药生物、机械设备、计 算机、电子、银行等，净买入金额分别为19.03亿元、17.06亿元、14.83亿元、14.71亿元、13.19亿元、 13.12亿元。 个股方面，8月13日有2028只个股获融资净买入，净买入金额在5000万元以上的有112股。其中，17股获 融资净买入额超2亿元。东方财富获融资净买入额居首，净买入7.83亿元；融资净买入金额居前的还有 药明康德、新易盛、贵州茅台、国泰海通、菲利华、工业富联、中信证券、东山精密等，净买入额分别 为6.71亿元、5.17亿元、4.56亿元、4.5亿元、4.45亿元、3.68亿元、3.53亿元、3.07亿元。 ...

Core Viewpoint - The article highlights the increasing trend of interim dividend announcements among A-share listed companies, with a total proposed payout of 829.02 billion yuan as of August 13, 2025, reflecting a strong commitment to shareholder returns and stable financial management [1] Group 1: Interim Dividend Trends - As of August 13, 2025, 65 A-share listed companies have disclosed their interim dividend plans, with a total proposed payout of 829.02 billion yuan [1] - Several companies are initiating interim dividends for the first time, with industry leaders leading the way in distributing substantial dividends [1][2] - The trend of increasing cash dividends aligns with regulatory encouragement and investor expectations, indicating a positive market reception [1] Group 2: Company-Specific Dividend Plans - Hikvision plans to distribute a cash dividend of 4 yuan per 10 shares, totaling approximately 3.6 billion yuan, supported by a revenue of 418.18 billion yuan and a net profit of 56.57 billion yuan for the first half of the year [2] - Changshu Bank has achieved double-digit growth in revenue and net profit for 16 consecutive quarters, proposing a cash dividend of 0.15 yuan per share, totaling 4.97 billion yuan, which is 25.27% of its net profit [3] - Weisheng Information plans to distribute a cash dividend of 2.5 yuan per 10 shares, totaling 1.22 billion yuan, with a net profit of 3.05 billion yuan, reflecting a 40% payout ratio [3] Group 3: Industry Leaders and Their Performance - China Mobile reported a revenue of 543.8 billion yuan and a net profit of 84.2 billion yuan, proposing an interim dividend of 2.75 HKD per share, totaling approximately 54.2 billion yuan [4] - China Unicom achieved a revenue exceeding 200 billion yuan and a profit of 17.7 billion yuan, proposing a dividend of 0.1112 yuan per share, totaling around 3.48 billion yuan [5] - CATL, benefiting from dual business segments, reported a revenue of 178.9 billion yuan and a net profit of 30.5 billion yuan, proposing a cash dividend of 10.07 yuan per 10 shares, totaling 4.57 billion yuan [5] - WuXi AppTec achieved a revenue of 207.99 billion yuan and a net profit of 85.61 billion yuan, proposing a cash dividend of 3.5 yuan per 10 shares, totaling 1.003 billion yuan [5]

Market Performance - Hong Kong stock market recorded its best single-day performance since early May, driven by interest subsidy policies, improving geopolitical conditions, and rising risk appetite ahead of tech giants' earnings season [1][2] - The Hang Seng Index saw a significant increase despite net outflows of $1 billion from southbound funds, indicating growing local market risk sentiment [1] Sector Performance - Healthcare, technology, and consumer sectors led the gains, with notable stock price increases following the Chinese government's announcement of interest subsidies for eligible personal consumption loans [2] - Key performers included Innovent Biologics (+9%), WuXi AppTec (+6.2%), and Hansoh Pharmaceutical (+5.4%) in the healthcare sector, while Tencent Music (+15.6%) and Alibaba (+6.1%) excelled in technology [2] Tencent Financial Results - Tencent reported a 15% year-on-year revenue growth in Q2, exceeding expectations, with operating profit up 18% [3] - Game revenue increased by 22%, and advertising revenue rose by 20%, both surpassing forecasts [3] - Gross margin improved to 57%, reflecting strong performance in high-margin business areas despite previous concerns over AI-related capital expenditures [3] Goldman Sachs Ratings - Goldman Sachs initiated a "Buy" rating for Damai Entertainment, setting a 12-month target price of HK$1.38, citing its leading position in live event ticketing and IP licensing in China [4] - The company is expected to benefit from the growing demand for live entertainment, with projections indicating a sixfold growth in the sector over the next five years [4] Baidu's Business Outlook - Baidu is undergoing a significant transformation in its search business, with expectations of declining advertising revenue due to shifts in user behavior towards AI and social media [8][11] - The cloud business is anticipated to grow by 25% year-on-year in 2025, driven by strong demand for AI training and subscription models [8][11] Tencent Music Highlights - Tencent Music's Q2 revenue reached 4.4 billion RMB, a year-on-year increase of 18%, driven by strong online music service performance [12][13] - The number of SVIP users surpassed 15 million, contributing to an increase in average revenue per user (ARPU) [12][13] - Non-GAAP operating profit margin expanded to 33.5%, supported by effective cost control [12][13] Yonghui Superstores and Baoshan International - Yonghui Superstores reported a 13% year-on-year increase in net profit for Q2, driven by non-operating income and lower tax expenses [18] - Baoshan International's Q2 revenue declined by 12%, with same-store sales showing a significant drop, although gross margin exceeded expectations [19][20]

Stock Market Activity - The total trading amount for Shanghai Stock Connect today was 137.85 billion, while Shenzhen Stock Connect totaled 139.34 billion [1] - The top traded stocks in Shanghai included Kweichow Moutai with 3.15 billion, WuXi AppTec with 2.39 billion, and Cambricon Technologies with 2.22 billion [2] - In Shenzhen, the leading stocks were CATL with 3.96 billion, Zhongji Xuchuang with 2.45 billion, and NewEase with 2.31 billion [3] Sector Performance - The sectors with the highest gains included non-ferrous metals, PEEK materials, CPO, and photolithography machines, while coal, banking, ports, and logistics sectors saw declines [4] - The non-bank financial sector had a net inflow of 4.39 billion, followed by securities with 4.30 billion and communications with 1.93 billion [5] - The food and beverage sector experienced the largest net outflow of 2.33 billion, followed by semiconductors with 2.28 billion and banking with 1.96 billion [6] ETF Trading - The top ETFs by trading amount included Hong Kong Securities ETF with 24.64 billion, Hong Kong Innovative Drug ETF with 9.89 billion, and Hang Seng Technology ETF with 5.38 billion [7] - The ETFs with the highest growth in trading amount compared to the previous trading day included Broker ETF with 0.35 billion (up 224.38%) and Communication ETF with 1.04 billion (up 144.84%) [8] Futures Market - The four major futures contracts saw significant increases in both long and short positions, with the IH contract showing balanced increases, while the IF contract had slightly more short positions [9] Institutional Activity - Institutional buying was notable in stocks like Huadian Power with a 10% increase and 225 million bought, while stocks like Huadian Technology saw significant selling [10] - The overall activity of institutions decreased, with notable buying in PCB concept stocks and significant selling in PEEK material stocks [11] Retail Investor Activity - Retail investors showed moderate activity, with significant buying in China Great Wall and selling in Hengbao [12][13] - Quantitative funds also showed increased activity, with notable buying in Huasheng Technology and selling in Sainuo Medical [14]

文/新苏商记者张静文 具体来看，连云港恒瑞医药以4156亿元的总市值排在江苏A股上市公司市值第一位。今年以来，恒瑞医 药发展稳健，7月底，公司与英国制药巨头GSK达成约120亿美元合作协议，首付款5亿美元，刷新中国 药出海纪录。 前不久，美国《制药经理人》杂志发布了2025年全球制药企业50强榜单，恒瑞医药位列第46名，排名上 升2位。 同属医药生物行业的无锡药明康德以2894亿元的总市值紧随其后。2025上半年财报显示，上半年药明康 德实现营收207.99亿元，同比增长20.64%，实现归母净利润85.61亿元，同比增长101.92%。财报公布次 日，药明康德股价大涨7.72%。 东山精密在7月17日市值首次突破千亿大关，当天股票涨停。截至今日收盘，公司最新市值约为1090亿 元。从2024年年初至今，东山精密股价从17.71元/股涨至59.5元/股，涨幅高达236%。 8月13日，市场全天震荡走高，沪指突破去年10月8日高点，创近4年新高。沪深两市全天成交额2.15万 亿元，较上个交易日放量2694亿元，时隔114个交易日重回2万亿元上方，全市场超2700只个股上涨。 得益于行业好转和出海业务增长迅猛，徐 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 無錫藥明康德新藥開發股份有限公司 呈交日期： 2025年8月13日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | A | | 於香港聯交所上市 | 否 | | | 證券代號 (如上市) | | 說明 | 於上海證券交易所上市 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 事件 | | 已發行股份（不包括庫存股份）變動 佔有關事件前的現有已發 | | 庫存股份變動 | 每股發行/出售價 (註4) ...

Market Performance - On August 13, the medical services sector rose by 4.02%, led by Innovative Medical [1] - The Shanghai Composite Index closed at 3683.46, up 0.48%, while the Shenzhen Component Index closed at 11551.36, up 1.76% [1] Individual Stock Performance - The table lists various stocks in the medical services sector, with notable declines including *ST Bio down 4.95% and ST Zhongzhu down 2.66% [1] - Other stocks such as Lanwei Medical and Baicheng Pharmaceutical also experienced minor declines of 1.76% and 1.59% respectively [1] Capital Flow Analysis - The medical services sector saw a net inflow of 1.962 billion yuan from institutional investors, while retail investors experienced a net outflow of 1.888 billion yuan [3] - Notable stocks with significant net inflows from institutional investors include Yaoming Kande with 1.13 billion yuan and Kanglong Huacheng with 248 million yuan [3] - Conversely, retail investors showed significant outflows from stocks like Yaoming Kande and Kanglong Huacheng, indicating a shift in investor sentiment [3]

智通财经APP讯，药明康德(02359)发布公告，该公司于2025年8月13日斥资2799.04万元人民币回购29.2 万股A股，每股回购价格为91.91-98.83元人民币。 ...

Market Overview - A-shares experienced a significant rally, with the Shanghai Composite Index achieving an 8-day winning streak and reaching a new high since December 2021, closing at 3683.46 points, up 0.48% [1] - The total trading volume in the A-share market exceeded 2 trillion yuan for the first time since February 27, with a total of 21,756 billion yuan traded [1] - The Hong Kong stock market also saw substantial gains, with the Hang Seng Index rising over 2% and the Hang Seng Tech Index increasing over 3% [1] AI Industry - AI-related stocks surged, with notable gains including Guangku Technology and Robotech both hitting the 20% limit up, and Industrial Fulian also reaching the limit up [2][4] - Industrial Fulian reported a revenue of 360.76 billion yuan for the first half of 2025, a year-on-year increase of 35.58%, and a net profit of 12.11 billion yuan, up 38.61% [4][5] - The demand for AI servers is expected to grow significantly, driven by increased capital expenditures from major North American cloud service providers [4][5] Innovative Pharmaceuticals - The innovative drug sector saw strong performance, with Shouyao Holdings hitting the 20% limit up, and other companies like Microchip Biotech and WuXi AppTec also posting significant gains [6][8] - The National Medical Insurance Administration has established a "new drug pricing mechanism," which is expected to provide innovative drug manufacturers with greater pricing flexibility and efficiency [8] Humanoid Robotics - The humanoid robotics sector showed renewed activity, with companies like Shenglan Co. and Jieke Co. seeing substantial increases in stock prices [9][11] - The World Robot Conference held in Beijing highlighted advancements in embodied intelligent robots, with local governments offering subsidies for robot purchases [9][11] - The industry is expected to benefit from various supportive policies and events, including the upcoming World Humanoid Robot Games and other robotics-related conferences [11]

Market Overview - A-shares experienced a significant rally, with the Shanghai Composite Index achieving an 8-day winning streak and reaching a new high since December 2021, closing at 3683.46 points, up 0.48% [1] - The total trading volume in the A-share market exceeded 2 trillion yuan for the first time since February 27, indicating increased market activity [1] - The Hong Kong stock market also saw substantial gains, with the Hang Seng Index rising over 2% and the Hang Seng Tech Index increasing by more than 3% [1] AI Industry - Stocks in the AI industry chain surged, with notable gains including Guangku Technology and Robotech both hitting the 20% limit up, and Industrial Fulian also reaching the limit up [3][4] - Industrial Fulian reported a revenue of 360.76 billion yuan for the first half of 2025, a year-on-year increase of 35.58%, and a net profit of 12.113 billion yuan, up 38.61% [5] - The company attributed its growth to breakthroughs in AI technology and an expected increase in capital expenditure from major North American cloud service providers, which will drive demand for high-end AI servers [5][6] Innovative Drug Sector - The innovative drug sector saw strong performance, with Shouyao Holdings hitting the 20% limit up and other companies like Microchip Biotech and WuXi AppTec also experiencing significant gains [8][9] - The National Medical Insurance Administration has established a "new drug pricing mechanism," which is expected to provide innovative drug manufacturers with greater pricing flexibility and efficiency [10][11] Humanoid Robot Sector - The humanoid robot sector showed renewed activity, with companies like Shenglan Co. and Jieke Co. seeing substantial increases in stock prices, with several stocks hitting the limit up [13][14] - The World Robot Conference held in Beijing highlighted advancements in embodied intelligent robots, with local governments offering subsidies for robot purchases to stimulate the market [15]